I had a great chat with Pete Piliero, VP of Medical Affairs at Melinta Therapeutics.

We talk about: 

• Transitioning from clinical practice to med affairs
• Changes in how other groups in pharma see med affairs
• The differences between access and adoption (and how to impact both)
• Advances in patient engagement and much more

A quick note–the views expressed here are mine and Pete’s, and don’t reflect those of our employers.

At one point I reference the MAPS, Future of Medical Affairs report. You can view the whole report here: https://medicalaffairs.org/future-medical-affairs-2030/

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com